Literature DB >> 8562536

Cytomegalovirus retinitis: are intraocular devices the answer?

A Tufail1, G N Holland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8562536      PMCID： PMC505341          DOI： 10.1136/bjo.79.12.1066

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

1.  Retinal detachments in patients with cytomegalovirus retinitis.

Authors:  D A Jabs; C Enger; J Haller; S de Bustros
Journal:  Arch Ophthalmol       Date:  1991-06

2.  A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS.

Authors:  M A Jacobson; D Causey; B Polsky; D Hardy; M Chown; R Davis; J J O'Donnell; B D Kuppermann; M H Heinemann; G N Holland
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

3.  Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.

Authors:  R Anand; S D Nightingale; R H Fish; T J Smith; P Ashton
Journal:  Arch Ophthalmol       Date:  1993-02

4.  Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. UCLA CMV Retinopathy Study Group.

Authors:  G N Holland; R F Sison; D E Jatulis; M G Haslop; M J Sakamoto; N C Wheeler
Journal:  Ophthalmology       Date:  1990-02       Impact factor: 12.079

5.  High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial.

Authors:  N Singh; V L Yu; L Mieles; M M Wagener; R C Miner; T Gayowski
Journal:  Ann Intern Med       Date:  1994-03-01       Impact factor: 25.391

6.  Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

Authors:  D F Martin; D J Parks; S D Mellow; F L Ferris; R C Walton; N A Remaley; E Y Chew; P Ashton; M D Davis; R B Nussenblatt
Journal:  Arch Ophthalmol       Date:  1994-12

7.  Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation.

Authors:  J M Goodrich; M Mori; C A Gleaves; C Du Mond; M Cays; D F Ebeling; W C Buhles; B DeArmond; J D Meyers
Journal:  N Engl J Med       Date:  1991-12-05       Impact factor: 91.245

8.  Replacing ganciclovir implants.

Authors:  M G Morley; J S Duker; P Ashton; M R Robinson
Journal:  Ophthalmology       Date:  1995-03       Impact factor: 12.079

9.  Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis.

Authors:  W R Freeman; D N Friedberg; C Berry; J I Quiceno; M Behette; S C Fullerton; D Munguia
Journal:  Am J Ophthalmol       Date:  1993-12-15       Impact factor: 5.258
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.